Valeant gets investigative subpoena over former ties with Philidor
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
A sign for the headquarters of Valeant Pharmaceuticals International Inc is seen in Laval, Quebec June 14, 2016. REUTERS/Christinne Musch
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
(Reuters) - Canadian drugmaker Valeant Pharmaceuticals International Inc (NYSE: VRX) (NYSE: VRX) said on Wednesday it received an investigative subpoena from the California Department of Insurance in September over its ties to pharmacies and marketing.
The request follows allegations against Valeant that it used speciality pharmacy Philidor Rx Services Llc to force customers to pay higher prices for its drugs.
The subpoena seeks materials including documents concerning Valeant's former relationship with Philidor, now defunct, and certain California-based pharmacies, the marketing and distribution of its products in California, the company said in a filing. (http://bit.ly/2fEt78n)
Valeant, which owns eye care products maker Bausch & Lomb, used Philidor to overcome insurer reimbursement rejections of its medications, with Philidor resubmitting claims to insurers until they were approved, according to numerous media reports late last year. It has since severed ties with the pharmacy company.
The company said it was cooperating with the investigation.
(Reporting by Arunima Banerjee in Bengaluru; Editing by Andrew Hay)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Sees 'Encouraging' Short-Term Set-Up in Valeant (VRX)
- France's Hollande criticizes protectionism as 'worst response'
- Trudeau speaks with Trump about trade: prime minister's office
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!